Cybersecurity vulnerabilities in certain Medtronic CareLink programmers are at the center of the recent voluntary recall. (This story has been updated with an FDA statement.) See Also: A Legal ...

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

Medtronic plans to invest up to $90 million in Anteris Technologies Global Corp., a company that’s dual headquartered in ...

Dozens of patients were put at risk after two of the UK's leading transplant centres continued fitting a heart device - despite knowing of concerns it had a higher mortality rate than its rival ...

The FDA issued a Class I recall — the most serious recall classification — for some of Medtronic’s cardiac resynchronization therapy and implantable cardioverter defibrillators. Here are four things ...

General view of the logo of Medtronic, a healthcare technology and pharmaceutical company, seen at their plant, in Galway, Ireland, April 11, 2025. REUTERS/Clodagh Kilcoyne (Reuters) -Medical device ...

More and more medical studies show that heart issues in women are not only underdiagnosed but should be treated differently. A study Medtronic designed to test its Evolut TAVR (transcatheter aortic ...

"It is unknown at this time if there will be additional litigation surrounding this specific product," Rosalie Louis of Lynch ...

Anteris Technologies says Medtronic will make a strategic investment of up to $90 million in the transcatheter heart valve ...